Comments to FDA: Evaluating Drug Names for Similarities Share page: Docket Number: 2003N-0201 Letter to Daniel E. Troy, Esq. regarding whether there should be different trade-name evaluation procedures for different classes of drugs (Rx versus OTC). Download Document Issues: OTC Medicines Other Issues Branding Related Posts Press Releases and Statements CHPA Recognizes International Self-Care Day, Underscores Value of Consumer Healthcare Products Jul 24, 2024 Public Policy & Regulatory Press Releases and Statements Strengthening the Self-Care Community: CHPA Welcomes 15 New Members & Celebrates Longtime Partnerships Jul 22, 2024